ASX - By Stock
|
EYE |
Re:
Ann: Deferral of Proposed USA Medicare Changes
|
|
srr
|
13 |
3.3K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
13
|
3.3K
|
1
|
|
ASX - By Stock
|
DUR |
Re:
Ann: FY24 Earnings Guidance
|
|
srr
|
18 |
7.9K |
0 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
18
|
7.9K
|
0
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Dividend and Market Update 30 October 2023
|
|
srr
|
15 |
6.4K |
1 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
15
|
6.4K
|
1
|
|
ASX - By Stock
|
GTK |
Re:
Ann: Investor Presentation
|
|
srr
|
6 |
3.0K |
1 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
6
|
3.0K
|
1
|
|
ASX - By Stock
|
GTK |
Re:
Ann: Investor Presentation
|
|
srr
|
6 |
3.0K |
1 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
6
|
3.0K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Further Update of Proposed USA Medicare Changes
|
|
srr
|
8 |
2.5K |
6 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
8
|
2.5K
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Appendix 3Y Mr T Spurling
|
|
srr
|
12 |
3.2K |
4 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
12
|
3.2K
|
4
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Dividend and Market Update 30 October 2023
|
|
srr
|
15 |
6.4K |
1 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
15
|
6.4K
|
1
|
|
ASX - By Stock
|
TSK |
Re:
Ann: Quarterly Activity Report - Q2 FY24
|
|
srr
|
4 |
1.7K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
4
|
1.7K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
srr
|
16 |
3.9K |
0 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
16
|
3.9K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Trading Halt
|
|
srr
|
16 |
3.9K |
1 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
16
|
3.9K
|
1
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Market Update
|
|
srr
|
76 |
24K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
76
|
24K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Angle Closure Glaucoma
|
|
srr
|
28 |
6.0K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
28
|
6.0K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
srr
|
2.4K |
579K |
0 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
2.4K
|
579K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
srr
|
2.4K |
579K |
0 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
2.4K
|
579K
|
0
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Trading Update
|
|
srr
|
8 |
3.2K |
3 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
8
|
3.2K
|
3
|
|
ASX - By Stock
|
CLG |
Re:
Ann: FY23 Results Announcement
|
|
srr
|
74 |
24K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
74
|
24K
|
3
|
|
ASX - By Stock
|
DUR |
Re:
Ann: Change of Director's Interest Notice
|
|
srr
|
7 |
1.9K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
7
|
1.9K
|
0
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Change in substantial holding from WMI
|
|
srr
|
13 |
3.5K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Change in substantial holding from WMI
|
|
srr
|
13 |
3.5K |
1 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
DUR |
Re:
Interesting company
|
|
srr
|
47 |
21K |
2 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
47
|
21K
|
2
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Change in substantial holding from WMI
|
|
srr
|
13 |
3.5K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
DDH |
Re:
Ann: DDH1 and Perenti Scheme Implementation Agreement
|
|
srr
|
115 |
43K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
115
|
43K
|
1
|
|
ASX - By Stock
|
DUR |
Re:
Ann: DURATEC FY23 RESULTS WEBINAR DETAILS
|
|
srr
|
7 |
2.5K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
7
|
2.5K
|
1
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Change in substantial holding from WMI
|
|
srr
|
13 |
3.5K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
13
|
3.5K
|
1
|
|
ASX - By Stock
|
GTK |
Re:
Ann: Investor Presentation
|
|
srr
|
4 |
2.9K |
2 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
4
|
2.9K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Fundies Loading Up
|
|
srr
|
19 |
6.3K |
1 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
EVO |
Re:
Ann: EVO announces dividends and market update
|
|
srr
|
5 |
2.2K |
3 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
5
|
2.2K
|
3
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
srr
|
62 |
23K |
3 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
62
|
23K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
srr
|
2.4K |
579K |
9 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
2.4K
|
579K
|
9
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
srr
|
62 |
23K |
1 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
62
|
23K
|
1
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
srr
|
62 |
23K |
4 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
62
|
23K
|
4
|
|
ASX - By Stock
|
DUR |
Re:
Interesting company
|
|
srr
|
47 |
21K |
1 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
47
|
21K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
srr
|
2.4K |
579K |
4 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
2.4K
|
579K
|
4
|
|
ASX - By Stock
|
HCL |
Re:
Ann: Change in substantial holding
|
|
srr
|
4 |
1.7K |
0 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
4
|
1.7K
|
0
|
|
ASX - By Stock
|
TSK |
Re:
TASK turnaround profitable
|
|
srr
|
106 |
42K |
0 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
106
|
42K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
Ann: Notification of Full Year Results Webinar
|
|
srr
|
4 |
1.5K |
3 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
DUR |
Re:
Ann: PRESENTATION AT NWR VANTAGE POINT CONFERENCE
|
|
srr
|
1 |
946 |
1 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
1
|
946
|
1
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK Full Year 2023 Results Date & Conference Call Details
|
|
srr
|
10 |
4.4K |
2 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
10
|
4.4K
|
2
|
|
ASX - By Stock
|
TSK |
Re:
Ann: TASK Full Year 2023 Results Date & Conference Call Details
|
|
srr
|
10 |
4.4K |
0 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
10
|
4.4K
|
0
|
|
ASX - By Stock
|
GTK |
Re:
Ann: Half-Year Results Investor Briefing
|
|
srr
|
6 |
2.7K |
3 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
6
|
2.7K
|
3
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
srr
|
2.4K |
579K |
5 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
2.4K
|
579K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Change in substantial holding
|
|
srr
|
7 |
2.4K |
4 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
7
|
2.4K
|
4
|
|
ASX - By Stock
|
GTK |
Re:
Ann: Half Year Results Announcement Date
|
|
srr
|
1 |
669 |
1 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
1
|
669
|
1
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Director retiring at Annual Meeting
|
|
srr
|
9 |
1.8K |
3 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
9
|
1.8K
|
3
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Director retiring at Annual Meeting
|
|
srr
|
9 |
1.8K |
2 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
9
|
1.8K
|
2
|
|
ASX - By Stock
|
EVO |
Re:
Ann: Director retiring at Annual Meeting
|
|
srr
|
9 |
1.8K |
1 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
9
|
1.8K
|
1
|
|
ASX - By Stock
|
DUR |
Re:
Ann: Upgraded FY23 Guidance
|
|
srr
|
1 |
1.3K |
4 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
1
|
1.3K
|
4
|
|
ASX - By Stock
|
ARX |
Re:
Ann: AROA secures first FDA clearance for ENIVO system
|
|
srr
|
4 |
2.2K |
4 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
4
|
2.2K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Ann: FDA Clears iTrack Advance for US Launch
|
|
srr
|
45 |
13K |
3 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
45
|
13K
|
3
|
|